Ron shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Ron shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Ron shRNA Plasmid (h)

Product Specs
ItemRon shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-36434-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namemacrophage stimulating 1 receptor
NCBI Gene AliasesCD136, CDw136, NPCA3, PTK8, RON, SEA, p185-Ron

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancerMolecular carcinogenesisNovember 1, 2021Kato A, Ng S, Thangasamy A, Han H, Zhou W, Raeppel S, Fallon M, Guha S, Ammanamanchi S.

(2) Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinomaInternational journal of oncologyAugust 1, 2019Kim SA, Lee KH, Lee DH, Lee JK, Lim SC, Joo YE, Chung IJ, Noh MG, Yoon TM.

(3) Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cellsInternational journal of oncologyApril 1, 2015Xia Y, Lian S, Khoi PN, Yoon HJ, Han JY, Chay KO, Kim KK, Jung YD.

(4) RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinomaAuris, nasus, larynxApril 1, 2014Kim SA, Yoon TM, Lee DH, Park YL, Lee KH, Lim SC, Joo YE, Lee JK.

(5) Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancerCancer researchFebruary 1, 2014Kawada I, Hasina R, Arif Q, Mueller J, Smithberger E, Husain AN, Vokes EE, Salgia R.

(6) RON confers lapatinib resistance in HER2-positive breast cancer cellsCancer lettersOctober 28, 2013Wang Q, Quan H, Zhao J, Xie C, Wang L, Lou L.

(7) EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cellsInternational journal of oncologyMarch 1, 2013Park JS, Khoi PN, Joo YE, Lee YH, Lang SA, Stoeltzing O, Jung YD.

(8) Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response-1 in gastric cancer cellsJournal of cellular biochemistryApril 1, 2012Lee KE, Park JS, Khoi PN, Joo YE, Lee YH, Jung YD.

(9) RON is associated with tumor progression via the inhibition of apoptosis and cell cycle arrest in human gastric cancerPathology internationalFebruary 1, 2012Song YA, Park YL, Kim KY, Myung E, Chung CY, Cho SB, Lee WS, Jung YD, Kweon SS, Joo YE.

(10) MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cellsCarcinogenesisFebruary 1, 2011Park JS, Park JH, Khoi PN, Joo YE, Jung YD.

(11) Small interfering RNA targeting of Recepteur d'Origine Nantais induces apoptosis via modulation of nuclear factor-kappaB and Bcl-2 family in gastric cancer cellsOncology reportsSeptember 1, 2010Park JS, Park JH, Lee S, Joo YE, Jung YD.

(12) An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cellsCarcinogenesisAugust 1, 2010Liu HS, Hsu PY, Lai MD, Chang HY, Ho CL, Cheng HL, Chen HT, Lin YJ, Wu TJ, Tzai TS, et al.

(13) Macrophage stimulating protein may promote tubular regeneration after acute injuryJournal of the American Society of Nephrology : JASNOctober 1, 2008Cantaluppi V, Biancone L, Romanazzi GM, Figliolini F, Beltramo S, Galimi F, Camboni MG, Deriu E, Conaldi P, Bottelli A, et al.

Be the First to Write a Review!